XML 98 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Investments - Equity Investments Table (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   $ 1,167,187 $ 1,224,813  
Other-than-temporary impairment expense   (19,883) (11,805)  
Equity income, net   183,483 204,645 $ 226,750
Contributions   9,632 4,435 19,388
Distributions   (186,153) (213,516) (246,637)
Distributions in excess of cumulative earnings   (63,897) (41,385) (32,160)
Acquisitions and divestitures   (145,673)    
Balance at end of period $ 944,696 944,696 1,167,187 1,224,813
White Cliffs [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   40,753 45,623  
Other-than-temporary impairment expense   (19,883) 0  
Equity income, net   (1,086) 780  
Contributions   0 0  
Distributions   (32) (199)  
Distributions in excess of cumulative earnings   (3,657) (5,451)  
Acquisitions and divestitures   0    
Balance at end of period 16,095 16,095 40,753 45,623
Rendezvous [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   22,075 28,198  
Other-than-temporary impairment expense   0 0  
Equity income, net   (2,582) (2,155)  
Contributions   0 0  
Distributions   (677) (1,103)  
Distributions in excess of cumulative earnings   (2,702) (2,865)  
Acquisitions and divestitures   0    
Balance at end of period 16,114 16,114 22,075 28,198
Mont Belvieu JV [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   96,728 98,874  
Other-than-temporary impairment expense   0 0  
Equity income, net   29,475 33,991  
Contributions   0 0  
Distributions   (29,599) (33,944)  
Distributions in excess of cumulative earnings   (5,294) (2,193)  
Acquisitions and divestitures   0    
Balance at end of period 91,310 91,310 96,728 98,874
Texas Express Gathering [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   16,116 16,661  
Other-than-temporary impairment expense   0 0  
Equity income, net   6,384 4,508  
Contributions   75 0  
Distributions   (6,407) (4,533)  
Distributions in excess of cumulative earnings   (312) (520)  
Acquisitions and divestitures   0    
Balance at end of period 15,856 15,856 16,116 16,661
Texas Express Pipeline [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   188,925 195,189  
Other-than-temporary impairment expense   0 0  
Equity income, net   44,650 36,547  
Contributions   0 0  
Distributions   (44,902) (36,797)  
Distributions in excess of cumulative earnings   (3,986) (6,014)  
Acquisitions and divestitures   0    
Balance at end of period 184,687 184,687 188,925 195,189
Front Range Pipeline [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   196,632 199,881  
Other-than-temporary impairment expense   0 0  
Equity income, net   45,841 38,280  
Contributions   455 750  
Distributions   (46,193) (38,275)  
Distributions in excess of cumulative earnings   (4,019) (4,004)  
Acquisitions and divestitures   0    
Balance at end of period 192,716 192,716 196,632 199,881
Whitethorn LLC [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   149,690 156,729  
Other-than-temporary impairment expense   0 0  
Equity income, net   (3,417) 4,969  
Contributions   281 349  
Distributions   5,223 (6,428)  
Distributions in excess of cumulative earnings   (5,182) (5,929)  
Acquisitions and divestitures   0    
Balance at end of period 146,595 146,595 149,690 156,729
Cactus II [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   171,294 173,921  
Other-than-temporary impairment expense   0 0  
Equity income, net   11,696 18,237  
Contributions   0 3,336  
Distributions (1,800) (11,835) (18,404)  
Distributions in excess of cumulative earnings   (18,085) (5,796)  
Acquisitions and divestitures   (153,070)    
Balance at end of period 0 0 171,294 173,921
Saddlehorn [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   110,441 111,717  
Other-than-temporary impairment expense   0 0  
Equity income, net   21,491 30,878  
Contributions   0 0  
Distributions   (21,034) (31,403)  
Distributions in excess of cumulative earnings   (6,707) (751)  
Acquisitions and divestitures   0    
Balance at end of period 104,191 104,191 110,441 111,717
Panola [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   20,044 20,867  
Other-than-temporary impairment expense   0 0  
Equity income, net   2,343 2,188  
Contributions   0 0  
Distributions   (2,212) (2,188)  
Distributions in excess of cumulative earnings   (864) (823)  
Acquisitions and divestitures   0    
Balance at end of period 19,311 19,311 20,044 20,867
Mi Vida [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   51,763 55,031  
Other-than-temporary impairment expense   0 0  
Equity income, net   11,316 10,491  
Contributions   0 0  
Distributions   (11,113) (10,596)  
Distributions in excess of cumulative earnings   (3,104) (3,163)  
Acquisitions and divestitures   0    
Balance at end of period 48,862 48,862 51,763 55,031
Ranch Westex [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   979 18,898  
Other-than-temporary impairment expense   0 (11,805) (29,400)
Equity income, net   3,392 12,407  
Contributions   0 0  
Distributions   (3,392) (15,657)  
Distributions in excess of cumulative earnings   (8,376) (2,864)  
Acquisitions and divestitures   7,397    
Balance at end of period 0 0 979 18,898
Red Bluff Express [Member]        
Schedule of Equity Method Investments [Line Items]        
Balance at beginning of year   101,747 103,224  
Other-than-temporary impairment expense   0 0  
Equity income, net   13,980 13,524  
Contributions   8,821 0  
Distributions   (13,980) (13,989)  
Distributions in excess of cumulative earnings   (1,609) (1,012)  
Acquisitions and divestitures   0    
Balance at end of period $ 108,959 $ 108,959 $ 101,747 $ 103,224